Clinical trials assessing the optimal management of brain metastases--the state of play.
These three clinical trials offer the opportunity to answer the controversies and uncertainties that exist in managing patients with brain metastases: for patients with solitary brain metastasis there is the EORTC trial, for patients with NSCLC, where there is a certainty that the patient should receive radiotherapy, there is TACTIC, and where there is uncertainty of the benefit of radiotherapy there is QUARTZ. We would encourage all clinical oncologists seeing patients with brain metastases to consider patients for entry into any one of these trials.
Khanduri
S
S
Gerrard
G
G
Barton
R
R
Mulvenna
P
P
Lee
S M
SM
D001932:Brain Neoplasms / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000473:pathology*; D011379:Prognosis; D011788:Quality of Life; D011878:Radiotherapy; D013256:Steroids; D016896:Treatment Outcome
D013256:Steroids